Prevalence of Antibody to Lymphadenopathy-Associated Virus among Drug-Detoxification Patients in New York

Thomas J. Simra, Don C. Des Jareais, Michael Marmor, Stanley Yancovitz, Samuel Friedman, Jonathan Garber, Henry Cohen, Ciril Cabradilla, V. C. Kaiyanaraman

Research output: Contribution to journalLetterpeer-review

Abstract

To the Editor: Of the 4861 cases of the acquired immunodeficiency syndrome (AIDS) reported to the Centers for Disease Control (CDC) through June 18, 1984, 852 (18 per cent) occurred in persons in whom intravenous-drug use was the only known risk factor. The great majority of such cases (82 per cent) have occurred in the New York-New Jersey area.1 Lymphadcnopathy-associatcd virus2 and human T-ccll lymphotropic virus III3 are human retroviruses recently associated with AIDS. This letter reports the seroprevalence of antibody to lymphadenopathy-associatcd virus among New York City drug-detoxification patients without diagnosed AIDS. Scrum specimens were collected from 86 intravenous-drug.

Original languageEnglish (US)
Pages (from-to)467-468
Number of pages2
JournalNew England Journal of Medicine
Volume311
Issue number7
DOIs
StatePublished - Aug 16 1984

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Prevalence of Antibody to Lymphadenopathy-Associated Virus among Drug-Detoxification Patients in New York'. Together they form a unique fingerprint.

Cite this